# Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome

Study · id `cardio:ct-nct07736196` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07736196](<https://clinicaltrials.gov/study/NCT07736196>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT07736196

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 300 participants.

## Technical summary

Registry record NCT07736196. Randomized; no masking; primary purpose treatment. Start 2026-07-15 (anticipated); primary completion 2029-07-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 300 participants (planned count; ClinicalTrials.gov record NCT07736196, source copy `cardio:ctgov-nct07736196-2026-07-30`, retrieved 2026-10-31)
- Planned start: 2026-07-15 (anticipated) (ClinicalTrials.gov record NCT07736196, source copy `cardio:ctgov-nct07736196-2026-07-30`, retrieved 2026-10-31)
- Primary completion: 2029-07-30 (anticipated) (ClinicalTrials.gov record NCT07736196, source copy `cardio:ctgov-nct07736196-2026-07-30`, retrieved 2026-10-31)
- Completion: 2030-06-01 (anticipated) (ClinicalTrials.gov record NCT07736196, source copy `cardio:ctgov-nct07736196-2026-07-30`, retrieved 2026-10-31)
- Countries: Egypt (ClinicalTrials.gov record NCT07736196, source copy `cardio:ctgov-nct07736196-2026-07-30`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07736196-2026-07-30`, retrieved 2026-10-31)

## The registry's words

- Brief title: Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome
- Condition: Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
- Condition: Dual Anti-platelet Therapy
- Intervention (Drug): Aspirin-Free Strategy
- Intervention (Drug): Dual Antiplatelet Therapy
- Lead sponsor: Assiut University
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Assiut University (`cardio:org-assiut-university`)

## Provenance

Content hash: 1311fddb13cb8c36d11c625e4c21a60348ca08343fdd50557db54d7fcfb1574e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
